MM symposium

Dear member,

On behalf of Prof. Michel Delforge, chair of the MM committee, we are cordially inviting you to the upcoming:

  • Symposium “Optimizing the use of novel agents in multiple myeloma: recommendations on how to prevent and manage adverse event"
Date: Friday 20 October 2017
Location: Hof ter Musschen
Place: Brussels
 

 Announcement



PROGRAMME

Chairs: Chantal Doyen en Michel Delforge

15:00 - 15:10 Welcome

15:10 - 15:50 Part 1: Immunomodulatory drugs

15:10              2 case reports: Dr. Isabelle Vandebroek (AZ Nikolaas), Prof. Marie-Christiane Vekemans (UCL, Saint-Luc)

15:20              resentation: Prof. Nathalie Meuleman (Institut Jules Bordet)

15:50 - 16:30 Part 2: Proteasome inhibitors

15:50             2 case reports: Dr. Karel Fostier (UZ Brussel), Prof. Jo Caers (CHU de Liège)

16:00             Presentation: Prof. Michel Delforge (UZ Leuven)

16:30 - 17:00 Coffee break

17:00 - 17:40 Part 3: Monoclonal antibodies

17:00             1 case report: Dr. Philip Vlummens (UZ Gent)

17:05             Presentation: Dr. Niels Van de Donk (Vrije Universiteit Amsterdam, the Netherlands)

17:40 - 18:10 Part 4: Conventional drugs (steroids, chemo) and future agents

                      Presentation: Prof. Chantal Doyen (UCL, Mont-Godinne)

18:10 - 18-15 Concluding remarks: Prof. Michel Delforge

18:15 - 18:45 Drinks


Sponsors